Suppr超能文献

寻找心力衰竭新的治疗靶点和策略:基础科学的最新进展。

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

机构信息

King's College London British Heart Foundation Centre of Excellence, London, UK.

出版信息

Lancet. 2011 Aug 20;378(9792):704-12. doi: 10.1016/S0140-6736(11)60894-5.

Abstract

Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte--eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.

摘要

慢性心力衰竭尽管在最近的治疗进展后仍继续造成重大的医疗保健负担。最终导致慢性心力衰竭的关键病理生理过程是心脏对慢性疾病压力的重塑。在这里,我们回顾了对在复杂重塑过程中起作用的分子和细胞机制的最新理解,重点介绍了可能适合治疗干预的关键分子和途径。这些途径包括调节心肌细胞肥大、钙稳态、能量代谢和细胞存活的途径,以及发生在心肌细胞之外的过程,例如心肌血管和细胞外基质。我们还讨论了我们目前理解中的主要差距,批判性地审视了迄今为止用于发现靶点的传统方法,并考虑了可能加速具有临床相关性发现的新研究途径。

相似文献

1
In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.
Lancet. 2011 Aug 20;378(9792):704-12. doi: 10.1016/S0140-6736(11)60894-5.
2
Structural basis of ventricular remodeling: role of the myocyte.
Curr Heart Fail Rep. 2004 Apr-May;1(1):5-8. doi: 10.1007/s11897-004-0010-y.
3
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
Oxid Med Cell Longev. 2017;2017:3920195. doi: 10.1155/2017/3920195. Epub 2017 Jul 2.
6
MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure.
Expert Opin Ther Targets. 2016 Nov;20(11):1287-1300. doi: 10.1080/14728222.2016.1212017. Epub 2016 Jul 25.
7
Involvement of NADPH oxidases in cardiac remodelling and heart failure.
Am J Nephrol. 2007;27(6):649-60. doi: 10.1159/000109148. Epub 2007 Sep 27.
8
Signalling pathways linking cysteine cathepsins to adverse cardiac remodelling.
Cell Signal. 2020 Dec;76:109770. doi: 10.1016/j.cellsig.2020.109770. Epub 2020 Sep 4.
9
The dynamic interaction of the extracellular matrix in cardiac remodeling.
J Card Fail. 2002 Dec;8(6 Suppl):S314-8. doi: 10.1054/jcaf.2002.129258.
10
Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling.
Circulation. 2014 Dec 9;130(24):2162-72. doi: 10.1161/CIRCULATIONAHA.114.011195. Epub 2014 Oct 2.

引用本文的文献

1
Investigating the role of disulfidoptosis in spinal cord injury and development of a novel diagnostic model.
Acta Orthop Traumatol Turc. 2025 Jun 5;59(4):201-209. doi: 10.5152/j.aott.2025.24248.
2
Increased Plasma Pyruvate Kinase M2 (PK-M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications.
J Am Heart Assoc. 2025 Jan 21;14(2):e036170. doi: 10.1161/JAHA.124.036170. Epub 2025 Jan 16.
3
Exercise Training after Myocardial Infarction Attenuates Dysfunctional Ventricular Remodeling and Promotes Cardiac Recovery.
Rev Cardiovasc Med. 2022 Apr 19;23(4):148. doi: 10.31083/j.rcm2304148. eCollection 2022 Apr.
4
Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells.
Int J Mol Sci. 2024 May 26;25(11):5772. doi: 10.3390/ijms25115772.
5
Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives.
Front Cardiovasc Med. 2024 Apr 23;11:1369642. doi: 10.3389/fcvm.2024.1369642. eCollection 2024.
6
SerpinA3 Promotes Myocardial Infarction in Rat and Cell-based Models.
Mol Biotechnol. 2025 Jan;67(1):92-103. doi: 10.1007/s12033-023-00982-x. Epub 2023 Nov 25.
8
β-catenin ameliorates myocardial infarction by preventing YAP-associated apoptosis.
Clinics (Sao Paulo). 2023 Apr 2;78:100189. doi: 10.1016/j.clinsp.2023.100189. eCollection 2023.
9
Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice.
JACC Basic Transl Sci. 2022 Aug 17;7(9):859-875. doi: 10.1016/j.jacbts.2022.05.008. eCollection 2022 Sep.

本文引用的文献

1
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.
J Clin Invest. 2011 Jun;121(6):2301-12. doi: 10.1172/JCI44824. Epub 2011 May 2.
2
Programmed necrosis, not apoptosis, in the heart.
Circ Res. 2011 Apr 15;108(8):1017-36. doi: 10.1161/CIRCRESAHA.110.225730.
3
Systems biology of heart failure, challenges and hopes.
Curr Opin Cardiol. 2011 Jul;26(4):314-21. doi: 10.1097/HCO.0b013e328346597d.
4
Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.
Science. 2011 Mar 18;331(6023):1439-43. doi: 10.1126/science.1200113.
5
Emerging inflammasome effector mechanisms.
Nat Rev Immunol. 2011 Mar;11(3):213-20. doi: 10.1038/nri2936.
6
microRNAs in hypertrophy and heart failure.
Exp Biol Med (Maywood). 2011 Feb;236(2):125-31. doi: 10.1258/ebm.2010.010269.
7
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
Nature. 2011 Mar 10;471(7337):230-4. doi: 10.1038/nature09855. Epub 2011 Feb 9.
8
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.
Circulation. 2011 Feb 15;123(6):594-604. doi: 10.1161/CIRCULATIONAHA.110.982777. Epub 2011 Jan 31.
9
Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure.
Circulation. 2011 Feb 1;123(4):391-9. doi: 10.1161/CIRCULATIONAHA.110.950543. Epub 2011 Jan 17.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验